Please login to the form below

Not currently logged in
Email:
Password:

Dice

This page shows the latest Dice news and features for those working in and with pharma, biotech and healthcare.

Undeterred by aducanumab failure, Eisai and Biogen plough on

Undeterred by aducanumab failure, Eisai and Biogen plough on

one of the final throws of the dice for the much-discredited amyloid hypothesis of AD.

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • Quality in Care Diabetes 2018: the best in innovative diabetes care Quality in Care Diabetes 2018: the best in innovative diabetes care

    The Best Practice Dissemination and Sustainability award went to Ipswich Hospital NHS Trust for its work on The DICE Programme.

  • Deal Watch March 2016 Deal Watch March 2016

    In pharmaceuticals, Sanofi's deal with DiCE topped the Deal Watch chart with a headline value of $2.3bn. ... Acquisition – division. $5, 869. DiCE Molecules/ Sanofi. Technology platform to select and optimise drug-like ligands targeting a range of

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics